Airway Delivery of Hydrogel-Encapsulated Niclosamide for the Treatment of Inflammatory Airway Disease
Article
[키워드] activated
administration
Affect
airway
airway epithelial cell
airway epithelium
anthelminthic
applied
Asthma
asthmatic
Calu-3
cells
chronic obstructive
circumvent
CLCA1
clearance
comparable
Compound
COVID-19
delivery
disease
drugs
Effect
effective
encapsulation
Ex vivo
examined
explained
fibrosis
glycol
human airway epithelial
hydrospheres
in vitro
in vivo
Inflammatory
inflammatory airway disease
Influenza
inhibit
inhibited
inhibitory effect
intratracheal instillation
Local
mice
Nanospheres
niclosamide
pro-inflammatory
problems
proinflammatory
pulmonary disease
repurposing
respiratory syncytial virus
SARS-CoV-2
secretion
Side effects
TMEM16A
TMEM16F
Trachea
tracheas
Treatment
viral respiratory infections
were assessed
while
[DOI] 10.3390/ijms23031085 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/ijms23031085 PMC 바로가기 [Article Type] Article